Arthneeti
Sale is live|00:00:00
AG Ventures LtdQ1 FY22

AG Ventures Ltd Q1 FY22 Earnings Call Analysis

Revenue, margin, capex, fundraise and order book outlook from management commentary.

Price: 123P/E: 18.3Market Cap: ₹109 CrSector: Chemicals & Petrochemicals

Management growth scorecard

Revenue

Category 4

Margin

Category 3

Fundraise

N/A

Order

N/A

Capex

Yes

1 of 3 growth signals are positive — mixed outlook.

Full analysis

Revenue guidance

Category 4
  • Slight increase in sales volumes noted over the previous year.
  • Total income growth was moderate (4% YoY in Q4 FY2022).
  • Demand initially impacted by COVID third wave and geopolitical issues but positive sequential growth expected in Q1 FY2023 compared to Q4 FY2022.
  • Price increases taken to offset rising raw material and freight costs.
  • Phase one capacity expansion (5,500 MT) commissioned in Dec 2021, with total insoluble sulphur capacity at ~40,000 MT per annum.
  • Ramp-up of new capacity expected to take a few quarters, with utilization projected to start gradually by Q4 FY2023.
  • Overall growth expected from increased capacity, new orders, and improved wallet share.
  • Management confident that current external challenges and input cost pressures are short-term and will taper down soon.

Margin guidance

Category 3
  • The company expects demand for commercial vehicles to remain favorable, supporting growth in the insoluble sulphur business.
  • Capacity expansions have been completed, which will aid in gaining new orders and increasing wallet share.
  • Price increases have been implemented to offset rising raw material and freight costs; further price hikes are planned in upcoming quarters.
  • Despite recent inflationary pressures, management believes current challenges are short-term and will taper down.
  • The ramp-up of the newly commissioned 5,500 MT insoluble sulphur plant (part of total 40,000 MT capacity) will take a few quarters, indicating volume growth ahead.
  • Dividend payout policy targets 50% of PAT as dividends, signaling strong free cash flow generation.
  • Outlook includes focus on chemical business growth while investment business operates separately post-demerger.
  • Overall confidence expressed in expanding capacity and improving financials as external challenges ease.

3 more insights locked — sign up free to unlock

Fundraise plans

  • There is no explicit mention of any current or future fundraising plans through debt or equity in the provided transcript.
  • The company is undergoing a demerger creating two entities: one focusing on the chemical business (insoluble sulphur) and another as an investment company.
  • The investment company will focus on private equity and venture capital investments rather than listed equity.
  • The chemical business will focus on operations and pay out dividends, targeting 50% of PAT as dividend payout.
  • The Board will decide asset allocation and cash movements between the two companies before the demerger.
  • No specific plan for raising new debt or equity has been disclosed during this call.

Order book

  • The transcript does not provide specific figures or detailed information on the current or expected order book/pending orders for Oriental Carbon and Chemicals Limited.
  • However, the company expressed confidence in gaining new orders and increasing wallet share following the completion of capacity expansions.
  • The company mentioned a positive outlook supported by phased capacity ramp-ups, including the commissioning of a new insoluble sulphur plant and an additional sulphuric acid plant.
  • Demand was impacted initially due to external factors like COVID waves and geopolitical issues, but recent indications are positive for growth.
  • No explicit quantitative data on order book size or pending orders was disclosed in the provided pages of the transcript.

Capex plans

Yes
  • Phase one of the Insoluble Sulphur (IS) plant (5,500 MT p.a.) was commissioned in December 2021; total IS capacity ~40,000 MT p.a. (Page 3).
  • Additional sulphuric acid plant capacity of 50,000 MT p.a. commissioned at Dharuhera (Page 3).
  • Ramp-up of new capacity expected to take a few quarters (Page 3).
  • Expansion plans ongoing, more utilization anticipated by Q4 FY2023 (Page 13).
  • Post-demerger, the insoluble sulphur (chemical) company will focus on growth, paying ~50% PAT as dividend; retained earnings will be used for related business growth or dividend payout (Page 10).
  • Investment company will pursue specialized investments primarily in private equity and venture capital (both direct and fund investments) with 20-25% of net worth as a target allocation (Pages 15-16).
  • Future investments by investment company are under evaluation and could evolve over time (Page 6).

How does AG Ventures Ltd rank vs peers in Chemicals & Petrochemicals?

Pro feature
1AG Ventures Ltd
Rev 4Mar 3

See full Chemicals & Petrochemicals sector rankings

Want more stocks like AG Ventures Ltd?

Build an AI portfolio filtered by sector, market cap, and growth rank. Takes 2 minutes.

Build my portfolio